Complement C3 and other adipokines may promote insulin resistance (IR) by increasing phosphorylation and proteosomal degradation of insulin receptor substrates or by disturbing insulin receptor-substrate interaction [24]. The gene discussed is INSR; the disease is Insulin resistance.